PharmaDax Inc.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.pharmadax.com
Treatment of Dry Eye Disease Using Pro-ocularâ„¢ - A Proof of Concept, Safety, and Efficacy Study
Phase 2
- Conditions
- Keratoconjunctivitis SiccaDry Eye Syndrome
- Interventions
- Drug: Pro-ocularâ„¢ Topical GelDrug: Placebo Topical Gel
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- PharmaDax Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04884217
- Locations
- 🇨🇳
Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan
© Copyright 2025. All Rights Reserved by MedPath